Accès gratuit
Numéro
Med Sci (Paris)
Volume 26, Numéro 4, Avril 2010
Page(s) 417 - 421
Section M/S revues
DOI https://doi.org/10.1051/medsci/2010264417
Publié en ligne 15 avril 2010
  1. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357 : 266–81.
  2. Souberbielle JC, Prie D, Courbebaisse M, et al. Update on vitamin D and evaluation of vitamin D status. Ann Endocrinol (Paris) 2008; 69 : 501–10.
  3. Tretli S, Hernes E, Berg JP, et al. Association between serum 25(OH)D and death from prostate cancer. Br J Cancer 2009; 100 : 450–4.
  4. Tuohimaa P, Tenkanen L, Ahonen M, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk : a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004; 108 : 104–8.
  5. Fleet JC. Molecular actions of vitamin D contributing to cancer prevention. Mol Aspects Med 2008; 29 : 388–96.
  6. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006; 354 : 684–96.
  7. Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk : results of a randomized trial. Am J Clin Nutr 2007; 85 : 1586–91.
  8. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007; 92 : 2017–29.
  9. Sun X, Zemel MB. Calcium and 1,25-dihydroxyvitamin D3 regulation of adipokine expression. Obesity 2007; 15 : 340–8.
  10. Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009; 26 : 19–27.
  11. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117 : 503–11.
  12. Pilz S, Marz W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008; 93 : 3927–35.
  13. London GM, Guerin AP, Verbeke FH, et al. Mineral metabolism and arterial functions in end-stage renal disease : potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 2007; 18 : 613–20.
  14. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005; 94 : 483–92.
  15. Cardus A, Parisi E, Gallego C, et al. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int 2006; 69 : 1377–84.
  16. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health : lessons from vitamin D receptor null mice. Endocr Rev 2008; 29 : 726–76.
  17. Nakagawa K, Sasaki Y, Kato S, et al. 22-Oxa-1alpha, 25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis 2005; 26 : 1044–54.
  18. Tarcin O, Yavuz DG, Ozben B, et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009; 94 : 4023–30.
  19. Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure’ a systematic review and meta-analysis. J Hypertens 2009; 27 : 1948–54.
  20. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system : vitamins A and D take centre stage. Nat Rev Immunol 2010 (sous presse).
  21. Tanaci N, Karakose H, Guvener N, et al. Influence of 1,25-dihydroxyvitamin D3 as an immunomodulator in renal transplant recipients : a retrospective cohort study. Transplant Proc 2003; 35 : 2885–7.
  22. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311 : 1770–3.
  23. Aloia JF, Li-Ng M. Re : epidemic influenza and vitamin D. Epidemiol Infect 2007; 135 : 1095–6.
  24. Li YC. Renoprotective effects of vitamin D analogs. Kidney Int 2010 (sous presse).
  25. Ravani P, Malberti F, Tripepi G, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2009; 75 : 88–95.
  26. Sun J, Kong J, Duan Y, et al. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 2006; 291 : E315–22.
  27. Alborzi P, Patel NA, Peterson C, et al. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease : a randomized double-blind pilot trial. Hypertension 2008; 52 : 249–55.
  28. Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia) : the longitudinal aging study Amsterdam. J Clin Endocrinol Metab 2003; 88 : 5766–72.
  29. Bischoff-Ferrari HA, Willett WC, et al. Fracture prevention with vitamin D supplementation : a meta-analysis of randomized controlled trials. JAMA 2005; 293 : 2257–64.
  30. Autier P, Gandini S. Vitamin D supplementation and total mortality : a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167 : 1730–7.
  31. Tissandié E, Guéguen Y, Lobaccaro JM, et al. Vitamine D : métabolisme, régulation et maladies associées. Med Sci (Paris) 2006; 22 : 1095–100.
  32. Prié D, Ureña Torres P, Friedlander G. Le facteur de croissance des fibroblastes 23 et son récepteur Klotho : un nouvel axe de régulation du bilan du phosphate. Med Sci (Paris) 2009; 25 : 489–95.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.